Tetra Bio Pharma Inc (TBP.CA) Stock Price, Quote, News and Overview
TSX:TBP - Toronto Stock Exchange - CA88166Y1007 - Common Stock - Currency: CAD
TBP.CA Quote, Performance and Key Statistics
TSX:TBP (3/6/2023, 7:00:00 PM)
0.025
0 (0%)
The current stock price of TBP.CA is 0.025 CAD. In the past year, price decreased by -64.29%.
TBP.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.59 | 3.04B | ||
| CRON.CA | CRONOS GROUP INC | 14.44 | 1.00B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 6.29 | 753.99M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | 53.09 | 581.84M | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 533.28M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 378.23M | ||
| ACB.CA | AURORA CANNABIS INC | 10.37 | 335.74M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 25.98 | 326.14M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 273.26M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | 30.33 | 243.66M | ||
| HITI.CA | HIGH TIDE INC | N/A | 242.31M | ||
| HLS.CA | HLS THERAPEUTICS INC | N/A | 157.20M |
Related stock screener links
About TBP.CA
Company Profile
Tetra Bio-Pharma, Inc. engages in the discovery and development of cannabinoid-based drugs and treatments. The company is headquartered in Orleans, Ontario and currently employs 33 full-time employees. The company went IPO on 2008-04-15. The firm has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The firm has a pipeline of formulations and drug delivery systems with a portfolio of assets in early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II study.
Company Info
Tetra Bio Pharma Inc
2316 St-Joseph Blvd.
ORLEANS ONTARIO K1C 1E8 CA
CEO: Richard Giguere
Employees: 33
Phone: 13436890714.0
Tetra Bio Pharma Inc / TBP.CA FAQ
What is the stock price of Tetra Bio Pharma Inc today?
The current stock price of TBP.CA is 0.025 CAD.
What is the ticker symbol for Tetra Bio Pharma Inc stock?
The exchange symbol of Tetra Bio Pharma Inc is TBP and it is listed on the Toronto Stock Exchange exchange.
On which exchange is TBP.CA stock listed?
TBP.CA stock is listed on the Toronto Stock Exchange exchange.
What is Tetra Bio Pharma Inc worth?
Tetra Bio Pharma Inc (TBP.CA) has a market capitalization of 10.58M CAD. This makes TBP.CA a Nano Cap stock.
How many employees does Tetra Bio Pharma Inc have?
Tetra Bio Pharma Inc (TBP.CA) currently has 33 employees.
What are the support and resistance levels for Tetra Bio Pharma Inc (TBP.CA) stock?
Tetra Bio Pharma Inc (TBP.CA) has a support level at 0.02. Check the full technical report for a detailed analysis of TBP.CA support and resistance levels.
Should I buy Tetra Bio Pharma Inc (TBP.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TBP.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TBP.CA, evaluating the profitability, health, valuation and growth aspects
- Tetra Bio Pharma Inc (TBP.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Tetra Bio Pharma Inc (TBP.CA) Sales and EPS estimates to see what analysts future expectations are.
- Tetra Bio Pharma Inc (TBP.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Tetra Bio Pharma Inc (TBP.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- Tetra Bio Pharma Inc (TBP.CA) Stock Chart to make your own analysis
- Tetra Bio Pharma Inc (TBP.CA) Latest news and press-releases to stay up to date.
Does Tetra Bio Pharma Inc (TBP.CA) stock pay dividends?
TBP.CA does not pay a dividend.
What is the Price/Earnings (PE) ratio of Tetra Bio Pharma Inc (TBP.CA)?
Tetra Bio Pharma Inc (TBP.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.09).
TBP.CA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to TBP.CA. When comparing the yearly performance of all stocks, TBP.CA is a bad performer in the overall market: 86.45% of all stocks are doing better.
TBP.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to TBP.CA. TBP.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
TBP.CA Financial Highlights
Over the last trailing twelve months TBP.CA reported a non-GAAP Earnings per Share(EPS) of -0.09. The EPS increased by 7.3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
TBP.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to TBP.CA. The Buy consensus is the average rating of analysts ratings from 5 analysts.